To facilitate investigation of the molecular mechanisms of tumor cell radiosensitivities, we have generated a set of clones with different radiosensitivities from a human glioma cell line U-251 MG-Ho. Forty-four colonies were isolated by subjecting parent cells to the mutagen N-methylnitrosourea and then irradiating these cells with increasing doses of x-rays. About half of the clones displayed different radiosensitivities than the parent cells. We selected one of the most sensitive clones ( ) ()X3i and one of the most resistant clones Y6 for further study. Isoeffective doses for these two clones differed by about a factor of 1.7; the relative radiosensi-tivities of both clones were stable for at least 30 cell culture passages. These two c...
Recent data suggest that the differences in radiosensitivity between cell lines can be related to di...
Glioblastoma (GBM), a Grade IV brain tumour, is a well-known radioresistant cancer. To investigate o...
Glioblastoma (GBM), a Grade IV brain tumour, is a well-known radioresistant cancer. To investigate o...
To facilitate investigation of the molecular mechanisms of tumor cell radiosensitivities, we have ge...
AbstractTo facilitate investigation of the molecular mechanisms of tumor cell radiosensitivities, we...
AbstractTo facilitate investigation of the molecular mechanisms of tumor cell radiosensitivities, we...
Radiotherapy is one of the conventional treatments for solid tumors. Investigation of tumor radiores...
AIM: Determination of in-vitro radiosensitivity and genetic alterations of cell cultures derived fro...
examined DNA damage responses and repair in four human glioma cell lines (A7, U87, T98G, and U373) a...
Human malignant glioma exhibits considerable clinical radioresistance. It has been postulated that t...
Human malignant glioma exhibits considerable clinical radioresistance. It has been postulated that t...
The response of tumour cells in vitro to ionising radiation can, to a certain extent, predict the re...
The goal of this study was to develop an assay that makes possible the assessment of the glioma cell...
Glioblastoma (GBM), a Grade IV brain tumour, is a well-known radioresistant cancer. To investigate o...
Human cells cultured in vitro are substantially different from each other in their radiosensitivity....
Recent data suggest that the differences in radiosensitivity between cell lines can be related to di...
Glioblastoma (GBM), a Grade IV brain tumour, is a well-known radioresistant cancer. To investigate o...
Glioblastoma (GBM), a Grade IV brain tumour, is a well-known radioresistant cancer. To investigate o...
To facilitate investigation of the molecular mechanisms of tumor cell radiosensitivities, we have ge...
AbstractTo facilitate investigation of the molecular mechanisms of tumor cell radiosensitivities, we...
AbstractTo facilitate investigation of the molecular mechanisms of tumor cell radiosensitivities, we...
Radiotherapy is one of the conventional treatments for solid tumors. Investigation of tumor radiores...
AIM: Determination of in-vitro radiosensitivity and genetic alterations of cell cultures derived fro...
examined DNA damage responses and repair in four human glioma cell lines (A7, U87, T98G, and U373) a...
Human malignant glioma exhibits considerable clinical radioresistance. It has been postulated that t...
Human malignant glioma exhibits considerable clinical radioresistance. It has been postulated that t...
The response of tumour cells in vitro to ionising radiation can, to a certain extent, predict the re...
The goal of this study was to develop an assay that makes possible the assessment of the glioma cell...
Glioblastoma (GBM), a Grade IV brain tumour, is a well-known radioresistant cancer. To investigate o...
Human cells cultured in vitro are substantially different from each other in their radiosensitivity....
Recent data suggest that the differences in radiosensitivity between cell lines can be related to di...
Glioblastoma (GBM), a Grade IV brain tumour, is a well-known radioresistant cancer. To investigate o...
Glioblastoma (GBM), a Grade IV brain tumour, is a well-known radioresistant cancer. To investigate o...